Combining anti-cancer drugs and antioxidant agents do enhance anti-carcinogenic and anti-proliferative effects compared to chemotherapy alone.13,14 Rutin and apigenin, as anti-oxidant agents, induce apoptosis in MCF-7 cancer cells through p53-dependent pathway, increasing anti-tumor activity of tamoxifen on cancer cells.15 Here, TP53 is linked to cancer.